Literature DB >> 28642352

Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.

Colin P Derdeyn, Gregory J Zipfel, Felipe C Albuquerque, Daniel L Cooke, Edward Feldmann, Jason P Sheehan, James C Torner.   

Abstract

PURPOSE: The aim of this statement is to review the current data and to make suggestions for the diagnosis and management of both ruptured and unruptured brain arteriovenous malformations.
METHODS: The writing group met in person and by teleconference to establish search terms and to discuss narrative text and suggestions. Authors performed their own literature searches of PubMed, Medline, or Embase, specific to their allocated section, through the end of January 2015. Prerelease review of the draft statement was performed by expert peer reviewers and by the members of the Stroke Council Scientific Oversight Committee and Stroke Council Leadership Committee.
RESULTS: The focus of the scientific statement was subdivided into epidemiology; diagnosis; natural history; treatment, including the roles of surgery, stereotactic radiosurgery, and embolization; and management of ruptured and unruptured brain arteriovenous malformations. Areas requiring more evidence were identified.
CONCLUSIONS: Brain arteriovenous malformations are a relatively uncommon but important cause of hemorrhagic stroke, especially in young adults. This statement describes the current knowledge of the natural history and treatment of patients with ruptured and unruptured brain arteriovenous malformations, suggestions for management, and implications for future research.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; arteriovenous malformations; cerebral hemorrhage; diagnosis; embolization, therapeutic; intracranial hemorrhages; neurosurgery; radiosurgery

Mesh:

Year:  2017        PMID: 28642352     DOI: 10.1161/STR.0000000000000134

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  44 in total

1.  Maximum Nidus Depth as a Risk Factor of Surgical Morbidity in Eloquent Brain Arteriovenous Malformations.

Authors:  Bikei Ryu; Koji Yamaguchi; Tatsuya Ishikawa; Fukui Atsushi; Go Matsuoka; Seiichiro Eguchi; Akitsugu Kawashima; Yoshikazu Okada; Takakazu Kawamata
Journal:  Acta Neurochir Suppl       Date:  2021

2.  Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study.

Authors:  Cindy Tiseo; Antonio Carolei
Journal:  Intern Emerg Med       Date:  2018-11-07       Impact factor: 3.397

Review 3.  Targeted endovascular treatment for ruptured brain arteriovenous malformations.

Authors:  Kun Hou; Kan Xu; Xuan Chen; Tiefeng Ji; Yunbao Guo; Jinlu Yu
Journal:  Neurosurg Rev       Date:  2019-11-13       Impact factor: 3.042

4.  Effect of A Randomized trial of Unruptured Brain Arteriovenous Malformation on Interventional Treatment Rates for Unruptured Arteriovenous Malformations.

Authors:  Alexandra S Reynolds; Monica L Chen; Alexander E Merkler; Abhinaba Chatterjee; Iván Díaz; Babak B Navi; Hooman Kamel
Journal:  Cerebrovasc Dis       Date:  2019-08-21       Impact factor: 2.762

5.  Safety and Effectiveness of First-line Endovascular Management of Low-Grade Brain Arteriovenous Malformations : Single Center Experience in 145 Patients.

Authors:  Maichael Talaat; Eimad Shotar; Kévin Premat; Anne-Laure Boch; Mariette Delaitre; Pierre-Yves Borius; Aurelien Nouet; Stéphanie Lenck; Atika Talbi; Awad Bessar; Mohammed Taema; Ahmed Bessar; Farouk Hassan; Tamer S Elserafy; Etienne Lefevre; Vincent Degos; Nader Sourour; Frédéric Clarençon
Journal:  Clin Neuroradiol       Date:  2022-05-13       Impact factor: 3.649

Review 6.  Complete seizure-free rates following interventional treatment of intracranial arteriovenous malformations: a systematic review and meta-analysis.

Authors:  James C Mamaril-Davis; Pedro Aguilar-Salinas; Mauricio J Avila; Peter Nakaji; Robert W Bina
Journal:  Neurosurg Rev       Date:  2022-01-06       Impact factor: 3.042

7.  Interrater Reliability in the Measurement of Flow Characteristics on Color-Coded Quantitative DSA of Brain AVMs.

Authors:  K H Narsinh; K Mueller; J Nelson; J Massachi; D C Murph; A Z Copelan; S W Hetts; V V Halbach; R T Higashida; A A Abla; M R Amans; C F Dowd; H Kim; D L Cooke
Journal:  AJNR Am J Neuroradiol       Date:  2020-10-29       Impact factor: 3.825

8.  Treatment Outcomes of Endovascular Embolization Only in Patients with Unruptured Brain Arteriovenous Malformations: A Subgroup Analysis of ARUBA (A Randomized Trial of Unruptured Brain Arteriovenous Malformations).

Authors:  A I Qureshi; O Saeed; S Sahito; I Lobanova; J Liaqat; F Siddiq; C R Gomez
Journal:  AJNR Am J Neuroradiol       Date:  2020-02-27       Impact factor: 3.825

9.  Interventions for treating brain arteriovenous malformations in adults.

Authors:  Susanna M Zuurbier; Rustam Al-Shahi Salman
Journal:  Cochrane Database Syst Rev       Date:  2019-09-10

10.  Cerebral Arteriovenous Malformation Recurrence After Complete Surgical Excision in an Adult: Case Report and Review of the Literature.

Authors:  Daniel Loh; Vincent Ng
Journal:  Cureus       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.